glp 1 discontinuation Reasons for GLP1 RA in the past 6 months, ranked by November Blog - What happens

2025 Jan 2;8(1):e2457349

Critically, the limitations of conventional cancer therapies-including efficacy-toxicity tradeoffs and therapeutic resistance-highlight an urgent need for innovative approaches where bioelectromagnetic strategies may offer transformative potential

Prokocimer, M

synergy research IGF-1 elevation occurs gradually and remains within physiological ranges Exogenous HGH release: Sharp spike in serum GH within 1-3 hours of injection Rapid decline as injected protein is metabolized Does not align with natural circadian GH secretion patterns Can produce supraphysiological GH levels depending on dose IGF-1 elevation is dose-dependent and can exceed physiological ranges Side Effect Profile Comparison Published literature documents distinctly different adverse event profiles for these two approaches